Harvard Can't Reverse USPTO On Mouse-Testing Patent

Law360, New York (May 16, 2013, 6:12 PM EDT) -- A Virginia federal judge on Wednesday tossed Harvard University and DuPont Co.’s challenge to a U.S. Patent and Trademark Office decision that a patent for a clinical testing method that uses transgenic mice had expired, ruling the decision was reasonable based on available evidence.

According to U.S. District Judge Liam O’Grady, the USPTO had not violated the Administrative Procedure Act when it determined that the disputed patent — U.S. Patent Number 5,925,803, owned by Harvard and exclusively licensed to DuPont — had expired based on an...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.